Dienogest in long-term treatment of endometriosis

Figures & data

Figure 1 Structural formula of the progestin, dienogest, compared with naturally occurring progesterone.

Figure 2 Change in visual analog scale (VAS) score during the placebo-controlled (A) and the extension (B) studies.^54,62

Note: Reprinted in part from Strowitzki T et al,⁵⁴ with permission from Elsevier.

Figure 3 Increase over time in the proportion of cases assessed as “marked or moderate” for global improvement, overall improvement of subjective symptoms during non-menstruation, and overall improvement of objective findings.⁵⁸

Note: Reprinted from Momoeda et al⁶³ with permission from John Wiley & Sons.

StrowitzkiTFaustmannTGerlingerCSeitzCDienogest in the treatment of endometriosis-associated pelvic pain: A 12-week, randomized, double-blind, placebo-controlled studyEur J Obstet Gynecol Reprod Biol2010151219319820444534

 PubMed Web of Science ®Google Scholar

PetragliaFHornungDSeitzCReduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatmentArch Gynecol ObstetJune 172011 [Epub ahead of print.]

 PubMed Web of Science ®Google Scholar

HaradaTMomoedaMTaketaniYDienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trialFertil Steril200991367568118653184

 PubMed Web of Science ®Google Scholar

MomoedaMHaradaTTerakawaNLong-term use of dienogest for the treatment of endometriosisJ Obstet Gynaecol Res20093561069107620025633

 PubMed Web of Science ®Google Scholar